Company intelligence / Profile preview

New Day Skin

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

NewDay Skin is a biotechnology-driven skincare company that develops advanced dermatological products using recombinant human collagen technology. Founded by former Eli Lilly executive Wei-Li Shao, the company aims to bring pharmaceutical-grade protein engineering to the consumer skincare market. Their flagship products utilize bio-designed proteins to support skin structure and health, offering a high-efficacy alternative to traditional topical treatments. NewDay Skin focuses on bridging the gap between biotechnology and daily skincare routines through science-backed formulations. The company is headquartered in San Francisco and targets the premium skincare and anti-aging markets.

Therapeutic areas: Dermatology
Modalities: Recombinant proteinCosmetic
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on New Day Skin.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on New Day Skin.

Explore the full profile